Filed before 2025Filed 1 March 2024
RYNE Biotechnology Inc. raised $30M
RYNE Biotechnology Inc., a biotech company based in Cambridge, MA, raised $30M in a new equity round, according to a filing dated 1 March 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 March 2024
- Round
- Equity round
- Amount sold
- $30M
- Offering size
- $81.8M
- Investors so far
- 9
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 81% of the 1,434 tracked raises with an amount filed in 2024, and than 59% of the 138 in biotech.
RYNE Biotechnology Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 1 Mar 2024 | New filing | $30M | This raise |
More with Cure Ventures on the board
- Tasca Therapeutics Corp$48.1M
- Crosslink Therapeutics Inc.$4.25M
- Alessa Therapeutics, Inc.$25.4M
- Deep 6 AI Inc.$26.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.